OVARIAN CANCER

For what age women should be preventive ovariectomy, between different gynecological physician there is a considerable difference. Jacobs Oram and the Royal College of Obstetrics and Gynecology doctors on preventive attitude ovariectomized done a survey, the results showed that: only 2% to gynecologists for women aged 40 to 44 the ovary; 20% of doctors agreed with 45 to 49-year-old women's ovary; 51% think Resectability aged over 49-year-old women's ovary; 85% agree that postmenopausal women with ovarian. Alaska gynecologists, 35% agree with women aged 40 to 44 the ovary; 81% agree with women aged 45 to 49 the ovary; 95% agree with women over the age of 49, the ovary.
Some of the literature suggested that the age for women aged ≥ 40 ovariectomized preventive purposes. However, while some other articles that only deal with ≥ 45 years of age patients with preventive ovariectomy. It is clear that the majority of women with ovarian also not aware of estrogen replacement therapy (estrogen replacement therapy, ERT) the importance, from the reported in the literature it is not difficult to see that the compliance ERT not ideal, however, the role of estrogen loss is real. After ovariectomy, the ERT begin compliance was 31% to 89%; The long-term application, a decrease of 13% to 51%. Under existing ERT compliance of the relevant information can be estimated preventive ovariectomized will lead to the age of 45 or more young women to shorten life expectancy. For example, a 35-year-old women, in preventive ovary after, if they failed to ERT, then her life expectancy will decrease 1.4 years. Siddle, proved to hysterectomy for women, ovarian failure will be the age of natural menopause, as early as four years (45.4? ? .0 49.5-right? ? .04), And 34% of women in the two years after emerging ovarian failure and menopause symptoms .
Thus, clinicians must be aware of ovarian hysterectomy after reservation for women should be ahead of ERT treatment.

Tags: age, early, eat, ert, estrogen, gynecological, head, life, ovarian, ovary, patients, preventive, symptoms, therapy, treatment, women

Health, will be right recurrent ovarian cancer surgery and chemotherapy again whether there has been significant controversy. Fourth Military Medical University Xijing Hospital director of obstetrics and gynecology professor Detang, has nearly 10 years of the 38 treated patients with recurrent epithelial ovarian cancer clinical data were analyzed retrospectively after that, again recurrent ovarian cancer surgery and chemotherapy, can further improve the survival rate of patients.

Tags: cancer, cases, chemotherapy, clinical, early, eat, ovarian, patients, rate, surgery, survival, therapy, treatment, tumor, tumors

Denmark Gronloud such report, as paclitaxel plus platinum chemotherapy after complete remission in patients with ovarian cancer, if recurrence of a solitary lesion again cytoreductive surgery may improve survival. (Eur J Surg Oncol 2005,31:67)

In the retrospective study selected criteria: 1 Guide to the residual initial stage operation and confirmed by histological examination of epithelial ovarian cancer; (2) complete remission after first-line treatment; 3. Imaging confirmed pots peritoneal metastasis; (4) Surgical resection of lesions for the purpose.

Tags: age, cancer, cases, cell, chemotherapy, eat, examination, metastasis, ovarian, paclitaxel, patients, rate, resection, residual, study, surgery, surgical, survival, therapy, time, treatment, tumor, tumors

A large number of pre-clinical data and the right abdominal anatomy, physiology and biology of ovarian cancer have suggested that understanding, abdominal local cytotoxic drug treatment for ovarian cancer is very reasonable. Intraperitoneal chemotherapy Phase I clinical trial confirmed the chemotherapy drugs and intraperitoneal chemotherapy safety of the technology itself, confirmed the intraperitoneal chemotherapy in the pharmacokinetic advantages.

In some multi-center Phase II clinical trials, surgical results confirmed that about 20% to 40% of second-tier category to cisplatin-based chemotherapy in patients with celiac complete remission, the part of the residual cancer patients <0.5 cm before  acceptable to platinum-based chemotherapy effective systemic System .

Tags: abdominal, administration, age, cancer, carboplatin, cause, chemotherapy, cisplatin, clinical, days, drug, drugs, eat, group, incidence, infusion, injection, intraperitoneal, intravenous, ovarian, paclitaxel, pain, patients, rate, reduce, residual, second, study, surgical, survival, taxol, therapy, time, toxicity, treatment, tumor

Researchers reported that the joint use of both cisplatin and paclitaxel chemotherapy drug for ovarian cancer achieved better clinical remission rate and a higher survival rate, this new program has become advanced ovarian cancer patients with standard treatment programs.

From the European Organization for Cancer Research and Treatment of Dr Piccart, a group of researchers across the Atlantic to the two large-scale clinical trials group that cisplatin and paclitaxel (TP) both chemotherapy treatment of advanced ovarian cancer with significant advantages.

Tags: age, anti, cancer, chemotherapy, cisplatin, clinical, drug, eat, grams, group, history, ovarian, paclitaxel, patients, rate, study, survival, therapy, treatment, tumor, tumors

Ovarian cancer is the gynecologic diseases, from childhood to old age may occur, according to the degree of malignancy, into benign and malignant tumors of the junction. Ovarian located in the pelvis, as superficial malignant easy aware of the organization, are often found already late, is the main threat to women's health malignancy. Slower development of benign ovarian tumors, small benign tumor more asymptomatic; Medium-sized benign tumor may have bloating and abdominal discomfort, patients often palpable mass, the tumor can produce tremendous oppression symptoms. The rapid tumor growth, invasion to the surrounding tissue, cause abdominal pain, bloating, bleeding, vaginal bleeding; Merger fever infection; Tumor necrosis have ulcers, bloody ascites, advanced with weight loss, fatigue, anemia, cachexia performance. 

Tags: abdominal, age, benign, bleeding, blood, cancer, cause, diet, eat, fat, growth, head, malignant, mass, oppression, ovarian, pain, patients, symptoms, tea, tumor, tumors, women

(1) life Conditioning
1, the personal attention sometimes, suitable living environment, adequate exercise, not overstrain. Particularly in long-term therapy, should rest, and maintain physical strength, should be nutrient-rich diet, with attention to the change in the weather changes clothes to avoid bacteria, viruses and other infections.
2, the appropriate useful life of physical and mental health, excessive, harmful to patients. However, during chemotherapy after surgery and not sex life, to question the basic physical state after the resumption before the beginning. Terminally ill patients should avoid sexual life.
(2) diet conditioning
Ovarian cancer eating conditioning is very important. After surgical treatment, clinical seen qi deficiency, spleen and stomach slump, the existing lack of nutrients, organisms dysfunction. Thus in modulating diet, we should pay attention to proper nutritional supplements, heat, to the high-protein, high-vitamin food, but also conditioning the spleen and stomach function, exciting Wei Qi, restore chemical gas source, acquired strengthening of the party. In addition to food choices milk, eggs, the average patient to eat more fresh vegetables, fruits, protein and various vitamins, blah mother pork. Ovarian tumors after serving more attention should still Tiaojing body, nourishing the liver and kidney of goods, such as pomegranates, Mangosteen, loquat fruit, fig, banana, lemon, Longan, grapes, walnuts, mulberry, black sesame, watermelons, Melon, black fungus, watery gruel, yam flour, Lotus, chestnut, mung bean, Chinese prickly ash, placenta, carp, crucian carp, eggs, milk and so on. Diet also used conditioning.
(3) psychotropic
Maintain a healthy psychological state and optimistic mood is conducive to the normal endocrine regulatory activities, which will help enhance ovarian cancer effect. Practice has proved that where the spirit of optimism and confidence than adequate treatment, and doctors with better efficacy patients better, otherwise poor. Correct pessimism, negative psychological state and inspire incentive to overcome disease patients establish the confidence to achieve good results.

Tags: age, body, cancer, chemotherapy, clinical, confidence, diet, eat, eggs, life, ovarian, patients, physical, poor, protein, psychological, surgery, surgical, therapy, time, treatment, tumor, tumors

Ovarian cancer is the worst prognosis of gynecologic tumors. Patients with advanced epithelial ovarian cancer five-year survival rates generally below 30%, mainly in patients with relapsing most (about 75%), relapse after chemotherapy to poor results.

For the treatment of recurrent ovarian cancer chemotherapy drugs many, no less than 10 species, but only clinical remission rate of 20% to 30%, no progress median survival time (PFS) for 2 to 6 months, the median overall survival (OS) for six to 12 months. Therefore, to improve the efficacy of chemotherapy drugs delay, but the development of new drugs is very difficult, efficient use of existing drugs is an effective way to <BR>.

Tags: cancer, cases, chemotherapy, cisplatin, clinical, drug, drugs, early, eat, exploration, gene, group, method, ovarian, p53, paclitaxel, patients, pmtc, poor, positive, prognosis, rate, second, study, survival, taxol, therapy, time, treatment, tumor, tumors

Cytoreductive surgery in the treatment of ovarian cancer Comprehensive Application and prospects

Foreign Medical Obstetrics and Gynecology volumes in 1999 Vol 26 No. 2

Tianjin Medical University General Hospital of Obstetrics and Gynecology (300,052) of the new QU (Summary) if Mi (revision)

Abstract <BR> since the 1980s, complete cytoreductive surgery to cisplatin-based combination chemotherapy for ovarian cancer as a conventional model, cytoreductive surgery is the complete impact of the prognosis of patients with one of the important factors for recurrent ovarian cancer once again cytoreductive surgery still some value , but to improve the survival rate of patients is more important to be effective after chemotherapy treatment as a necessary complement. Early ovarian cancer retroperitoneal lymph node dissection is reasonable and significance of the still controversial.

Tags: abdominal, age, annex, anti, bleeding, blood, cancer, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, diagnosis, drug, drugs, early, eat, ert, exploration, gene, growth, incidence, increased, intraperitoneal, intravenous, life, lymph, malignant, metastasis, metastatic, method, mutation, node, ovarian, p53, patients, pelvic, physical, poor, positive, prognosis, quality, rate, reduce, resection, residual, response, second, staging, study, surgery, surgical, survival, therapy, time, toxicity, treatment, tumor, tumors

I. Overview

With the aging of the global trend of development, improve the economic status of women, more and more women start hormone replacement therapy (Hormone Replacement Therapy, HRT), to improve access to after menopause due to the decrease in the level of sex hormones related to various diseases. Clear evidence that: postmenopausal women with age, the incidence of coronary heart disease increased by about four times the fracture due to osteoporosis by 20%, died of complications due to pelvic fracture rate of 30%, after the 65-year-old Alzheimer's incidence rate increase every year <BR> and Application HRT can peer groups coronary heart disease risk 50% Alzheimer's risk reduced three times, especially worth mentioning is significantly reduced the incidence of rectal cancer. Long-term use of HRT cancer risk reduced year by year. HRT can also greatly improve the menopause, postmenopausal women with disease or ovarian surgery, radiotherapy in patients with a series of artificial menopause syndrome.

Tags: age, benign, blood, body, brca1, breast, cancer, carcinoma, care, cases, cause, cell, cells, clinical, cyst, cystic, diagnosis, diet, drug, early, eat, ert, estrogen, family, fat, gene, grams, group, groups, growth, gynecological, history, hrt, incidence, increased, injection, intravenous, life, lymph, malignant, metastasis, method, mutation, node, ovarian, patients, pelvic, positive, protein, quality, radiotherapy, rate, reduce, residual, risk, screening, second, study, surgery, surgical, survival, syndrome, therapy, time, treatment, tumor, tumors, usually, uterine, women